Chemence Medical—a manufacturer and distributor of adhesive-based medical devices—received clearance from the U.S. FDA to market and sell the Exofin Precision Pen as a new medical device for wound closure.
The precision pen is designed to enable medical providers greater versatility and exactness in closing wounds while also improving ease of use in applying topical skin adhesive.
The Exofin Precision Pen will supplement Chemence Medical’s other Exofin products.
“In listening to feedback from physicians, it became clear every patient is different and every procedure is unique in a variety of ways,” says Jeff Roberson, president of Chemence Medical. “Doctors and surgeons emphasized they wanted an adhesive that could be applied with precision, regardless of the wound size or location, even in the most delicate procedures.”
The Exofin Precision Pen features an adjustable tip that allows the user to control the adhesive width by supporting three different application methods in a single device: a micro-bristle brush for wide coverage, an inverted brush for narrow lines, and an angle precision tip for micro lines.
“Our continued mission with Exofin products is to enable doctors to achieve the perfect line every time,” says Roberson. “Whether it’s a substantial abdominal incision, a fine incision behind the ear or somewhere in between, the Exofin Precision Pen is ready to be that versatile tool for physicians to improve patient outcomes.”
Featured image: Chemence Medical unveils Exofin Precision Pen high viscosity tissue adhesive. Photo: Chemence Medical
